164 related articles for article (PubMed ID: 38374407)
1. METTL3-mediated m
Li B; Xiong X; Xu J; Peng D; Nie G; Wen N; Wang Y; Lu J
Oncogene; 2024 Mar; 43(14):1050-1062. PubMed ID: 38374407
[TBL] [Abstract][Full Text] [Related]
2. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
[TBL] [Abstract][Full Text] [Related]
4. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
5. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
6. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
Liu F; Yuan JH; Huang JF; Yang F; Wang TT; Ma JZ; Zhang L; Zhou CC; Wang F; Yu J; Zhou WP; Sun SH
Oncogene; 2016 Oct; 35(41):5422-5434. PubMed ID: 27065331
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract][Full Text] [Related]
9. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
[TBL] [Abstract][Full Text] [Related]
10. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L
Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA COX7C-5 promotes hepatocellular carcinoma progression via miR-581/ZEB2 axis.
Lin Y; Wang F; Zhong Y; Cheng NM; Xiong J; Zheng X; Zhou Y; Gao S; Li F; Wang Y; Yang X; Zhao B
Cell Signal; 2023 Jan; 101():110501. PubMed ID: 36273755
[TBL] [Abstract][Full Text] [Related]
12. Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis.
Su T; Zhang N; Wang T; Zeng J; Li W; Han L; Yang M
Cancer Res; 2023 Dec; 83(24):4080-4094. PubMed ID: 37756562
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
Yao J; Yang Z; Yang J; Wang ZG; Zhang ZY
Aging (Albany NY); 2021 May; 13(10):13726-13738. PubMed ID: 34023817
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
[TBL] [Abstract][Full Text] [Related]
15. HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Yang Y; Chen Q; Piao HY; Wang B; Zhu GQ; Chen EB; Xiao K; Zhou ZJ; Shi GM; Shi YH; Wu WZ; Fan J; Zhou J; Dai Z
Int J Cancer; 2020 Jan; 146(1):169-180. PubMed ID: 31090062
[TBL] [Abstract][Full Text] [Related]
16. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
[TBL] [Abstract][Full Text] [Related]
17. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.
Zhang Y; Wan X; Yang X; Liu X; Huang Q; Zhou L; Zhang S; Liu S; Xiong Q; Wei M; Qiu L; Zhang B; Han J
J Biol Chem; 2023 Sep; 299(9):105177. PubMed ID: 37611825
[TBL] [Abstract][Full Text] [Related]
18. METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC.
Fan Z; Gao Y; Zhang W; Yang G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
Biochem Biophys Res Commun; 2021 Mar; 546():169-177. PubMed ID: 33582561
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
20. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
